259P Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
Ming‐Lin Tsai, Heon Han, A.J. Montero, K.H. Tkaczuk, Hadeel Assad, Lajos Pusztai, Sara A. Hurvitz, Sharon Wilks, JM Specht, Rita Nanda, Monica Mita, Joyce O’Shaughnessy, IE Krop, Diana C. Medgyesy, JE Abraham, Shanu Modi, H. Li, Shikai Wu, Phillip M. Garfin, H.A. Burris
Topics & Concepts
MedicineTolerabilityInternal medicineNeutropeniaMetastatic breast cancerBreast cancerTriple-negative breast cancerAdverse effectOncologyNauseaCancerGastroenterologyChemotherapyHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchBreast Cancer Treatment Studies